Article
Structural Characterization of Cleaved, Soluble HIV-1 Envelope Glycoprotein Trimers
4 Jul 2013
Abstract excerpt
Human immunodeficiency virus type 1 (HIV-1) infection is a significant global public health problem for which development of an effective prophylactic vaccine remains a high scientific priority. Many concepts for a vaccine are focused on induction of appropriate titers of broadly neutralizing antibodies (bNAbs) against the viral envelope (Env) glycoproteins gp120 and gp41, but no immunogen has yet accomplished...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
